A detailed history of First Financial Corp transactions in Catalent, Inc. stock. As of the latest transaction made, First Financial Corp holds 111 shares of CTLT stock, worth $6,514. This represents 0.0% of its overall portfolio holdings.

Number of Shares
111
Previous 111 -0.0%
Holding current value
$6,514
Previous $6,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$42.56 - $59.82 $4,724 - $6,640
111 New
111 $6,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track First Financial Corp Portfolio

Follow First Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Financial Corp , based on Form 13F filings with the SEC.

News

Stay updated on First Financial Corp with notifications on news.